NASDAQ:SILK Silk Road Medical (SILK) Stock Forecast, Price & News $31.95 +0.52 (+1.65%) (As of 06/9/2023 ET) Add Compare Share Share Today's Range$31.19▼$32.1850-Day Range$29.76▼$46.1452-Week Range$28.98▼$58.04Volume500,586 shsAverage Volume606,139 shsMarket Capitalization$1.24 billionP/E RatioN/ADividend YieldN/APrice Target$48.25 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Silk Road Medical MarketRank™ ForecastAnalyst RatingModerate Buy2.60 Rating ScoreUpside/Downside51.0% Upside$48.25 Price TargetShort InterestHealthy9.01% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment0.57Based on 2 Articles This WeekInsider TradingSelling Shares$1.58 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.53) to ($1.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.35 out of 5 starsMedical Sector259th out of 987 stocksSurgical & Medical Instruments Industry25th out of 95 stocks 3.3 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 4 buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $48.25, Silk Road Medical has a forecasted upside of 51.0% from its current price of $31.95.Amount of Analyst CoverageSilk Road Medical has only been the subject of 4 research reports in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted9.01% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Silk Road Medical has recently decreased by 9.11%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 2.5 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Silk Road Medical this week, compared to 3 articles on an average week.Search Interest3 people have searched for SILK on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,584,409.00 in company stock.Percentage Held by InsidersOnly 6.70% of the stock of Silk Road Medical is held by insiders.Percentage Held by Institutions96.43% of the stock of Silk Road Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.53) to ($1.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -21.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -21.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 7.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Silk Road Medical (NASDAQ:SILK) StockSilk Road Medical, Inc. engages in the development and manufacturing of medical devices to treat neurovascular diseases. Its products include ENROUTE transcarotid neuroprotection system, ENROUTE transcarotid stent system, and ENROUTE transcarotid peripheral access kit. The company was founded by Tony M. Chou and Michi Garrison on March 21, 2007 and is headquartered in Sunnyvale, CA.Read More Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SILK Stock News HeadlinesJune 5, 2023 | markets.businessinsider.comCiti Keeps Their Buy Rating on Cooper Co (COO)May 30, 2023 | markets.businessinsider.comJohnson & Johnson (JNJ) Receives a New Rating from CitiJune 10, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 28, 2023 | seekingalpha.comSilk Road Medical: Speculative Appeal Is Seen HereMay 26, 2023 | markets.businessinsider.comB.Riley Financial Keeps Their Buy Rating on Silk Road Medical (SILK)May 26, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Earns Buy Rating from Analysts at CL KingMay 25, 2023 | americanbankingnews.comCL King Initiates Coverage on Silk Road Medical (NASDAQ:SILK)May 25, 2023 | markets.businessinsider.comStifel Nicolaus Remains a Buy on Silk Road Medical (SILK)June 10, 2023 | Legacy Research (Affiliate) (Ad)Sell Every Stock, Except ONE (Ticker Revealed)We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.May 23, 2023 | msn.comCL King Initiates Coverage of Silk Road Medical (SILK) with Buy RecommendationMay 22, 2023 | markets.businessinsider.comArgus Research Maintains Buy Rating for Silk Road Medical: Here's What You Need To KnowMay 22, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Given New $55.00 Price Target at ArgusMay 17, 2023 | markets.businessinsider.comStifel Nicolaus Keeps Their Buy Rating on Silk Road Medical (SILK)May 17, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Rating Lowered to Underperform at Wolfe ResearchMay 17, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Trading Down 8.7% on Insider SellingMay 16, 2023 | msn.comSilk Road Medical: Big Nearby Cap-Gain Medical Equipment Stock ProspectMay 16, 2023 | finance.yahoo.comHere’s Why Silk Road Medical (SILK) Declined in Q1May 14, 2023 | americanbankingnews.comErica J. Rogers Sells 3,000 Shares of Silk Road Medical, Inc (NASDAQ:SILK) StockMay 14, 2023 | americanbankingnews.comQ2 2023 Earnings Estimate for Silk Road Medical, Inc (NASDAQ:SILK) Issued By B. RileyMay 13, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) PT Lowered to $41.00 at Piper SandlerMay 12, 2023 | msn.comCitigroup Maintains Silk Road Medical (SILK) Buy RecommendationMay 12, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Shares Gap Down Following Weak EarningsMay 11, 2023 | msn.comPiper Sandler Maintains Silk Road Medical (SILK) Neutral RecommendationMay 11, 2023 | americanbankingnews.comSilk Road Medical (NASDAQ:SILK) Given New $50.00 Price Target at Stifel NicolausMay 10, 2023 | benzinga.comSilk Road Medical shares are trading lower after the company reported worse-than-expected Q1 EPS and sales results.May 10, 2023 | markets.businessinsider.comExpert Ratings for Silk Road MedicalMay 10, 2023 | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Silk Road Medical (SILK)See More Headlines SILK Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILK Company Calendar Last Earnings5/09/2023Today6/10/2023Next Earnings (Estimated)7/25/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees352Year FoundedN/APrice Target and Rating Average Stock Price Forecast$48.25 High Stock Price Forecast$60.00 Low Stock Price Forecast$27.00 Forecasted Upside/Downside+51.0%Consensus RatingModerate Buy Rating Score (0-4)2.60 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)($1.50) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,010,000.00 Net Margins-36.47% Pretax Margin-36.35% Return on Equity-50.13% Return on Assets-25.74% Debt Debt-to-Equity Ratio0.47 Current Ratio11.03 Quick Ratio10.21 Sales & Book Value Annual Sales$138.64 million Price / Sales8.93 Cash FlowN/A Price / Cash FlowN/A Book Value$4.30 per share Price / Book7.43Miscellaneous Outstanding Shares38,730,000Free Float36,134,000Market Cap$1.24 billion OptionableNot Optionable Beta1.18 Key ExecutivesErica J. RogersPresident, Chief Executive Officer & DirectorLucas W. BuchananChief Financial & Operating OfficerSumaira MacdonaldExecutive Director-MedicalTammy LeitsingerVP-Professional Education & Medical AffairsWilliam WhealonExecutive Vice President-Research & DevelopmentKey CompetitorsOrthoPediatricsNASDAQ:KIDSSI-BONENASDAQ:SIBNAtrionNASDAQ:ATRILeMaitre VascularNASDAQ:LMATLongview Acquisition Corp. IINYSE:LGVView All CompetitorsInsiders & InstitutionsLevel Four Advisory Services LLCSold 2,621 shares on 6/5/2023Ownership: 0.020%Macquarie Group Ltd.Sold 64,115 shares on 6/1/2023Ownership: 0.150%Prelude Capital Management LLCSold 10,721 shares on 6/1/2023Ownership: 0.030%Ameriprise Financial Inc.Bought 810 shares on 5/22/2023Ownership: 0.209%New York State Common Retirement FundSold 55,764 shares on 5/18/2023Ownership: 0.051%View All Insider TransactionsView All Institutional Transactions SILK Stock - Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 sell rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SILK shares. View SILK analyst ratings or view top-rated stocks. What is Silk Road Medical's stock price forecast for 2023? 5 brokerages have issued 1 year price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $27.00 to $60.00. On average, they predict the company's stock price to reach $48.25 in the next twelve months. This suggests a possible upside of 51.0% from the stock's current price. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts. How have SILK shares performed in 2023? Silk Road Medical's stock was trading at $52.85 at the beginning of 2023. Since then, SILK shares have decreased by 39.5% and is now trading at $31.95. View the best growth stocks for 2023 here. When is Silk Road Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 25th 2023. View our SILK earnings forecast. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings results on Tuesday, May, 9th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.39) by $0.04. The firm had revenue of $40.13 million for the quarter, compared to the consensus estimate of $40.69 million. Silk Road Medical had a negative net margin of 36.47% and a negative trailing twelve-month return on equity of 50.13%. The firm's revenue for the quarter was up 43.2% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.48) EPS. What ETFs hold Silk Road Medical's stock? ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), American CenturyFocused Dynamic Growth ETF (FDG), Hypatia Women CEO ETF (WCEO), Invesco Nasdaq Future Gen 200 ETF (QQQS), First Trust Small Cap Growth AlphaDEX Fund (FYC), Global X Aging Population ETF (AGNG), Principal Healthcare Innovators ETF (BTEC) and Principal U.S. Small-Cap Multi-Factor ETF (PSC). What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical issued an update on its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $176.00 million-$184.00 million, compared to the consensus revenue estimate of $180.27 million. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." Who are Silk Road Medical's major shareholders? Silk Road Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Wasatch Advisors LP (8.38%), BlackRock Inc. (6.93%), Clearbridge Investments LLC (4.46%), Kayne Anderson Rudnick Investment Management LLC (3.54%), American Century Companies Inc. (3.51%) and Fred Alger Management LLC (2.64%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Lucas W Buchanan, Lucas W Buchanan, Richard Ruedy and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $31.95. How much money does Silk Road Medical make? Silk Road Medical (NASDAQ:SILK) has a market capitalization of $1.24 billion and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.50) on an earnings per share basis. How many employees does Silk Road Medical have? The company employs 352 workers across the globe. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013. This page (NASDAQ:SILK) was last updated on 6/10/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.